Early Discontinuation of Empirical Antifungal Therapy and Biomarkers
NCT03538912
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
194
Enrollment
OTHER
Sponsor class
Conditions
Invasive Candidiasis
Interventions
OTHER:
Biomarker strategy
OTHER:
Routine strategy
Sponsor
University Hospital, Lille